{"transactions":[{"id":694548,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-08-06T21:20:06.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":10292,"price":68.57,"value":705722.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of the 25,000 RSUs from an August 1, 2025 grant of 75,000 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026."}],"balance_after":383868,"source":{"system":"sec-edgar","filing":"0001808968-26-000017","document":"form4-08062026_050802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000017/form4-08062026_050802.xml","form_type":"4"}},{"id":763900,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-26T20:30:13.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":12820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."}],"balance_after":12820,"derivative":{"underlying":"Common Stock","underlying_shares":12820},"source":{"system":"sec-edgar","filing":"0001193125-26-239431","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000119312526239431/ownership.xml","form_type":"4"}},{"id":763899,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:30:13.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":16000,"price":11.59,"value":185440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $11.57 to $11.65. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC\nstaff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":46935,"source":{"system":"sec-edgar","filing":"0001193125-26-239431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000119312526239431/ownership.xml","form_type":"4"}},{"id":768097,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-21T20:30:21.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":12417,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12417},"source":{"system":"sec-edgar","filing":"0001193125-26-234577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000119312526234577/ownership.xml","form_type":"4"}},{"id":768096,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:21.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":12417,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."}],"balance_after":62935,"source":{"system":"sec-edgar","filing":"0001193125-26-234577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000119312526234577/ownership.xml","form_type":"4"}},{"id":777671,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-05-15T21:20:06.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":2572,"price":72.46,"value":186367.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 6,250 shares on May 13, 2026."}],"balance_after":393998,"source":{"system":"sec-edgar","filing":"0001808968-26-000015","document":"form4-05152026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000015/form4-05152026_050501.xml","form_type":"4"}},{"id":777670,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-05-15T21:20:06.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":2100,"price":73.08,"value":153468.0,"ownership":{"direct":true},"balance_after":396570,"source":{"system":"sec-edgar","filing":"0001808968-26-000015","document":"form4-05152026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000015/form4-05152026_050501.xml","form_type":"4"}},{"id":777669,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-05-15T21:20:06.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":7221,"price":73.08,"value":527710.68,"ownership":{"direct":true},"balance_after":398670,"source":{"system":"sec-edgar","filing":"0001808968-26-000015","document":"form4-05152026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000015/form4-05152026_050501.xml","form_type":"4"}},{"id":777668,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-05-15T21:20:06.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":679,"price":73.06,"value":49607.74,"ownership":{"direct":true},"balance_after":405891,"source":{"system":"sec-edgar","filing":"0001808968-26-000015","document":"form4-05152026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000015/form4-05152026_050501.xml","form_type":"4"}},{"id":777667,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-05-15T21:20:06.000Z","date":"2026-05-13","kind":"grant","planned":true,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of the Issuer's common stock underlying restricted stock units (\"RSUs\") earned upon the vesting of performance-based restricted stock units (\"PSUs\") granted in December 2024. The Issuer's compensation committee of the board of directors certified the Issuer's achievement of a pre-established milestone set forth in the PSUs, as of May 13, 2026, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 6,250 shares on May 13, 2026 in connection with being earned and are scheduled to vest with respect to the remaining 6,250 shares on May 13, 2027."}],"balance_after":406570,"source":{"system":"sec-edgar","filing":"0001808968-26-000015","document":"form4-05152026_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000015/form4-05152026_050501.xml","form_type":"4"}},{"id":802056,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-04-23T21:20:06.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":2850,"price":70.91,"value":202093.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from an April 18, 2023 grant of 26,000 RSUs."}],"balance_after":394070,"source":{"system":"sec-edgar","filing":"0001808968-26-000013","document":"form4-04232026_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000013/form4-04232026_050401.xml","form_type":"4"}},{"id":844583,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-13T21:20:05.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":2662,"price":64.08,"value":170580.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 6,500 shares on March 11, 2026."}],"balance_after":396920,"source":{"system":"sec-edgar","filing":"0001808968-26-000011","document":"form4-03132026_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000011/form4-03132026_050301.xml","form_type":"4"}},{"id":844582,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-13T21:20:05.000Z","date":"2026-03-11","kind":"grant","planned":true,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock underlying restricted stock units (\"RSUs\") earned upon the vesting of performance-based restricted stock units (\"PSUs\") granted in December 2024. The Issuer's compensation committee of the board of directors certified the Issuer's achievement of a pre-established milestone set forth in the PSUs, as of March 11, 2026, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 6,500 shares on March 11, 2026 in connection with being earned and are scheduled to vest with respect to the remaining 6,500 shares on March 11, 2027."}],"balance_after":399582,"source":{"system":"sec-edgar","filing":"0001808968-26-000011","document":"form4-03132026_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000011/form4-03132026_050301.xml","form_type":"4"}},{"id":891398,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T22:20:09.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":7371,"price":69.36,"value":511252.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a February 15, 2025 grant of 70,000 RSUs."}],"balance_after":387082,"source":{"system":"sec-edgar","filing":"0001808968-26-000009","document":"form4-02202026_050205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000009/form4-02202026_050205.xml","form_type":"4"}},{"id":941389,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-12T22:20:11.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":2514,"price":76.45,"value":192195.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 5,250 RSUs from a January 7, 2022 grant of 21,000 RSUs."}],"balance_after":394453,"source":{"system":"sec-edgar","filing":"0001808968-26-000007","document":"form4-01122026_050107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000007/form4-01122026_050107.xml","form_type":"4"}},{"id":943552,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:21.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":3016,"price":77.48,"value":233679.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs."}],"balance_after":396967,"source":{"system":"sec-edgar","filing":"0001808968-26-000005","document":"form4-01082026_050118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000005/form4-01082026_050118.xml","form_type":"4"}},{"id":943551,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T22:20:21.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":5149,"price":76.95,"value":396215.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a January 3, 2025 grant of 70,000 RSUs."}],"balance_after":399983,"source":{"system":"sec-edgar","filing":"0001808968-26-000005","document":"form4-01082026_050118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000005/form4-01082026_050118.xml","form_type":"4"}},{"id":947911,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T22:20:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027."}],"balance_after":157500,"derivative":{"exercise_price":76.74,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0001808968-26-000003","document":"form4-01062026_050103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000003/form4-01062026_050103.xml","form_type":"4"}},{"id":947910,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-06T22:20:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025."}],"balance_after":405132,"source":{"system":"sec-edgar","filing":"0001808968-26-000003","document":"form4-01062026_050103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000003/form4-01062026_050103.xml","form_type":"4"}},{"id":955611,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-01-02T22:20:05.000Z","date":"2025-12-30","kind":"sale","planned":true,"acquired":false,"shares":8089,"price":76.64,"value":619940.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs."}],"balance_after":341875,"source":{"system":"sec-edgar","filing":"0001808968-26-000001","document":"form4-01022026_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896826000001/form4-01022026_050101.xml","form_type":"4"}},{"id":982359,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-03T22:20:05.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":3428,"price":79.07,"value":271051.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 7,812 shares on December 1, 2025."}],"balance_after":349964,"source":{"system":"sec-edgar","filing":"0001808968-25-000003","document":"form4-12032025_051202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896825000003/form4-12032025_051202.xml","form_type":"4"}},{"id":982358,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-12-03T22:20:05.000Z","date":"2025-12-01","kind":"grant","planned":true,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock underlying restricted stock units (\"RSUs\") earned upon the vesting of performance-based restricted stock units (\"PSUs\") granted in December 2024. On December 1, 2025, the Issuer's board of directors certified the Issuer's achievement of a pre-established milestone set forth in the PSUs, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 7,812 shares on December 1, 2025 in connection with being earned and are scheduled to vest with respect to the remaining 7,813 shares on December 1, 2026."}],"balance_after":353392,"source":{"system":"sec-edgar","filing":"0001808968-25-000003","document":"form4-12032025_051202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000180896825000003/form4-12032025_051202.xml","form_type":"4"}},{"id":1075231,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-08-06T00:30:04.000Z","date":"2025-08-05","kind":"sale","planned":true,"acquired":false,"shares":10739,"price":51.74,"value":555635.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 25,000 shares on August 1, 2025."}],"balance_after":337767,"source":{"system":"sec-edgar","filing":"0001415889-25-021130","document":"form4-08052025_080801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925021130/form4-08052025_080801.xml","form_type":"4"}},{"id":1075230,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-08-06T00:30:04.000Z","date":"2025-08-01","kind":"grant","planned":true,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock underlying restricted stock units (\"RSUs\") earned upon the vesting of performance-based restricted stock units (\"PSUs\") granted in December 2023. On August 1, 2025, the Issuer's board of directors certified the Issuer's achievement of a pre-established regulatory milestone set forth in the PSUs, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 25,000 shares on August 1, 2025 in connection with being earned and are scheduled to vest with respect to the remaining 50,000 shares in equal annual installments on August 1, 2026 and August 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025."}],"balance_after":348506,"source":{"system":"sec-edgar","filing":"0001415889-25-021130","document":"form4-08052025_080801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925021130/form4-08052025_080801.xml","form_type":"4"}},{"id":1135469,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T21:56:38.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":12417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders."}],"balance_after":12417,"derivative":{"underlying":"Common Stock","underlying_shares":12417},"source":{"system":"sec-edgar","filing":"0000950170-25-077172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000095017025077172/ownership.xml","form_type":"4"}},{"id":1142918,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-19T20:41:45.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":21093,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21093},"source":{"system":"sec-edgar","filing":"0000950170-25-074448","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000095017025074448/ownership.xml","form_type":"4"}},{"id":1142917,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:41:45.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":21093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":50518,"source":{"system":"sec-edgar","filing":"0000950170-25-074448","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000095017025074448/ownership.xml","form_type":"4"}},{"id":1166643,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-04-24T21:20:05.000Z","date":"2025-04-22","kind":"sale","planned":true,"acquired":false,"shares":2804,"price":48.736,"value":136655.744,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from an April 18, 2023 grant of 26,000 RSUs."}],"balance_after":273234,"source":{"system":"sec-edgar","filing":"0001415889-25-011290","document":"form4-04242025_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925011290/form4-04242025_050401.xml","form_type":"4"}},{"id":1253899,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-02-21T22:20:12.000Z","date":"2025-02-20","kind":"sale","planned":true,"acquired":false,"shares":3895,"price":50.124,"value":195232.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a February 15, 2025 grant of 70,000 RSUs."}],"balance_after":276038,"source":{"system":"sec-edgar","filing":"0001415889-25-005136","document":"form4-02212025_050208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925005136/form4-02212025_050208.xml","form_type":"4"}},{"id":1253898,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-02-21T22:20:12.000Z","date":"2025-02-19","kind":"sale","planned":true,"acquired":false,"shares":3897,"price":50.096,"value":195224.112,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a February 15, 2025 grant of 70,000 RSUs."}],"balance_after":279933,"source":{"system":"sec-edgar","filing":"0001415889-25-005136","document":"form4-02212025_050208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925005136/form4-02212025_050208.xml","form_type":"4"}},{"id":1305749,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-01-10T22:20:11.000Z","date":"2025-01-08","kind":"sale","planned":true,"acquired":false,"shares":2402,"price":44.5,"value":106889.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs and the vesting of 15,250 RSUs from January 7, 2022 grants totaling 41,000 RSUs."}],"balance_after":283830,"source":{"system":"sec-edgar","filing":"0001415889-25-001293","document":"form4-01102025_050107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001293/form4-01102025_050107.xml","form_type":"4"}},{"id":1305748,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-01-10T22:20:11.000Z","date":"2025-01-07","kind":"sale","planned":true,"acquired":false,"shares":2142,"price":45.34,"value":97118.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs."}],"balance_after":286232,"source":{"system":"sec-edgar","filing":"0001415889-25-001293","document":"form4-01102025_050107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001293/form4-01102025_050107.xml","form_type":"4"}},{"id":1308690,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T22:20:04.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026."}],"balance_after":175000,"derivative":{"exercise_price":46.54,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-25-001015","document":"form4-01072025_050101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001015/form4-01072025_050101.xml","form_type":"4"}},{"id":1308689,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T22:20:04.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 3, 2025 that vest in four equal installments over four years, commencing on January 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 445 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2024, and 401 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2024."}],"balance_after":288374,"source":{"system":"sec-edgar","filing":"0001415889-25-001015","document":"form4-01072025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925001015/form4-01072025_050101.xml","form_type":"4"}},{"id":1316241,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-01-03T22:21:36.000Z","date":"2024-12-31","kind":"sale","planned":true,"acquired":false,"shares":8279,"price":45.16,"value":373879.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs."}],"balance_after":217528,"source":{"system":"sec-edgar","filing":"0001415889-25-000580","document":"form4-01032025_100132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588925000580/form4-01032025_100132.xml","form_type":"4"}},{"id":1511604,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:27:41.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":21093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders."}],"balance_after":21093,"derivative":{"underlying":"Common Stock","underlying_shares":21093},"source":{"system":"sec-edgar","filing":"0001285550-24-000070","document":"wk-form4_1715977649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000128555024000070/wk-form4_1715977649.xml","form_type":"4"}},{"id":1516051,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-15T13:19:14.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":17153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17153},"source":{"system":"sec-edgar","filing":"0001285550-24-000056","document":"wk-form4_1715779144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000128555024000056/wk-form4_1715779144.xml","form_type":"4"}},{"id":1516050,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T13:19:14.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":17153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":29425,"source":{"system":"sec-edgar","filing":"0001285550-24-000056","document":"wk-form4_1715779144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000128555024000056/wk-form4_1715779144.xml","form_type":"4"}},{"id":1537937,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-22T21:20:08.000Z","date":"2024-04-19","kind":"sale","planned":true,"acquired":false,"shares":3361,"price":24.894,"value":83668.734,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from an April 18, 2023 grant of 26,000 RSUs."}],"balance_after":225807,"source":{"system":"sec-edgar","filing":"0001415889-24-011329","document":"form4-04222024_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924011329/form4-04222024_050401.xml","form_type":"4"}},{"id":1538587,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-04-19T21:20:09.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":1307,"price":25.135,"value":32851.445,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from an April 16, 2020 grant of 10,000 RSUs."}],"balance_after":229168,"source":{"system":"sec-edgar","filing":"0001415889-24-011247","document":"form4-04192024_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924011247/form4-04192024_050401.xml","form_type":"4"}},{"id":1639141,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T21:10:52.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025."}],"balance_after":175000,"derivative":{"exercise_price":25.69,"expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001415889-24-004106","document":"form4-02162024_040237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004106/form4-02162024_040237.xml","form_type":"4"}},{"id":1639140,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T21:10:52.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025."}],"balance_after":230475,"source":{"system":"sec-edgar","filing":"0001415889-24-004106","document":"form4-02162024_040237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924004106/form4-02162024_040237.xml","form_type":"4"}},{"id":1681895,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-01-10T21:08:01.000Z","date":"2024-01-09","kind":"sale","planned":true,"acquired":false,"shares":5443,"price":29.0148,"value":157927.5564,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs and the vesting of 15,250 RSUs from January 7, 2022 grants totaling 41,000 RSUs."}],"balance_after":160475,"source":{"system":"sec-edgar","filing":"0001415889-24-000915","document":"form4-01102024_090152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924000915/form4-01102024_090152.xml","form_type":"4"}},{"id":1681894,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-01-10T21:08:01.000Z","date":"2024-01-08","kind":"sale","planned":true,"acquired":false,"shares":2237,"price":28.6403,"value":64068.3511,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a January 5, 2023 grant of 26,000 RSUs."}],"balance_after":165918,"source":{"system":"sec-edgar","filing":"0001415889-24-000915","document":"form4-01102024_090152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924000915/form4-01102024_090152.xml","form_type":"4"}},{"id":1683117,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-01-09T21:29:38.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":10107,"price":27.1488,"value":274392.9216,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 301 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2023."}],"balance_after":168155,"source":{"system":"sec-edgar","filing":"0001415889-24-000854","document":"form4-01092024_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588924000854/form4-01092024_090130.xml","form_type":"4"}},{"id":1698934,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-12-28T22:12:36.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit granted on December 28, 2023 that vests in four equal installments over four years, commencing on December 29, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 316 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2023."}],"balance_after":177961,"source":{"system":"sec-edgar","filing":"0001415889-23-016992","document":"form4-12282023_101229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923016992/form4-12282023_101229.xml","form_type":"4"}},{"id":1876685,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-26T18:11:18.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":17153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."}],"balance_after":17153,"derivative":{"underlying":"Common Stock","underlying_shares":17153},"source":{"system":"sec-edgar","filing":"0001285550-23-000062","document":"wf-form4_168512466161562.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000128555023000062/wf-form4_168512466161562.xml","form_type":"4"}},{"id":1916630,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-20T20:05:47.000Z","date":"2023-04-18","kind":"grant","planned":true,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on April 18, 2023, and vests over four years, with 25% of the shares underlying the option vesting on April 18, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 18, 2024."}],"balance_after":65000,"derivative":{"exercise_price":52.96,"expiration_date":"2033-04-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001415889-23-006750","document":"form4-04202023_080437.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006750/form4-04202023_080437.xml","form_type":"4"}},{"id":1916629,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-04-20T20:05:47.000Z","date":"2023-04-18","kind":"sale","planned":true,"acquired":false,"shares":1211,"price":52.0437,"value":63024.9207,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from an April 16, 2020 grant of 10,000 RSUs."}],"balance_after":102645,"source":{"system":"sec-edgar","filing":"0001415889-23-006750","document":"form4-04202023_080437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006750/form4-04202023_080437.xml","form_type":"4"}},{"id":1916628,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2023-04-20T20:05:47.000Z","date":"2023-04-18","kind":"grant","planned":true,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on April 18, 2023 that vest in four equal installments over four years, commencing on April 18, 2024."}],"balance_after":103856,"source":{"system":"sec-edgar","filing":"0001415889-23-006750","document":"form4-04202023_080437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923006750/form4-04202023_080437.xml","form_type":"4"}},{"id":2055869,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2023-01-12T21:36:40.000Z","date":"2023-01-11","kind":"sale","acquired":false,"shares":2244,"price":44.3596,"value":99542.9424,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 15,250 RSUs from January 7, 2022 grants of a total of 41,000 RSUs."}],"balance_after":77856,"source":{"system":"sec-edgar","filing":"0001415889-23-000879","document":"form4-01122023_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000879/form4-01122023_090129.xml","form_type":"4"}},{"id":2055868,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2023-01-12T21:36:40.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":2273,"price":42.9329,"value":97586.4817,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 15,250 RSUs from January 7, 2022 grants of a total of 41,000 RSUs."}],"balance_after":80100,"source":{"system":"sec-edgar","filing":"0001415889-23-000879","document":"form4-01122023_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000879/form4-01122023_090129.xml","form_type":"4"}},{"id":2056784,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2023-01-11T23:13:34.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":731,"price":41.6562,"value":30450.6822,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs."}],"balance_after":82373,"source":{"system":"sec-edgar","filing":"0001415889-23-000836","document":"form4-01112023_110124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000836/form4-01112023_110124.xml","form_type":"4"}},{"id":2059234,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T21:52:57.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024."}],"balance_after":65000,"derivative":{"exercise_price":39.42,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001415889-23-000689","document":"form4-01092023_090149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000689/form4-01092023_090149.xml","form_type":"4"}},{"id":2059233,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2023-01-09T21:52:57.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 263 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2022 and 277 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022."}],"balance_after":83104,"source":{"system":"sec-edgar","filing":"0001415889-23-000689","document":"form4-01092023_090149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588923000689/form4-01092023_090149.xml","form_type":"4"}},{"id":2253636,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-05-27T20:27:36.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":6179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders."}],"balance_after":6179,"derivative":{"exercise_price":9.71,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":6179},"source":{"system":"sec-edgar","filing":"0001420506-22-001135","document":"doc4_1012.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000142050622001135/doc4_1012.xml","form_type":"4"}},{"id":2253635,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:27:36.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":9269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders."}],"balance_after":12272,"source":{"system":"sec-edgar","filing":"0001420506-22-001135","document":"doc4_1012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000142050622001135/doc4_1012.xml","form_type":"4"}},{"id":2292988,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2022-04-21T20:03:58.000Z","date":"2022-04-19","kind":"sale","acquired":false,"shares":897,"price":42.515,"value":38135.955,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from a April 16, 2020 grant of 10,000 RSUs."}],"balance_after":56564,"source":{"system":"sec-edgar","filing":"0001415889-22-004211","document":"form4-04212022_010449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000141588922004211/form4-04212022_010449.xml","form_type":"4"}},{"id":2438174,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T21:18:07.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on January 7, 2022 and vests in two equal installments over two years, commencing on January 7, 2023."}],"balance_after":50000,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-22-000397","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000397/edgar.xml","form_type":"4"}},{"id":2438173,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T21:18:07.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023."}],"balance_after":52500,"derivative":{"exercise_price":38.1,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001179110-22-000397","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000397/edgar.xml","form_type":"4"}},{"id":2438172,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-11T21:18:07.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Restricted stock units granted on January 7, 2022 that vest in two equal installments over two years, commencing on January 7, 2023."}],"balance_after":57461,"source":{"system":"sec-edgar","filing":"0001179110-22-000397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000397/edgar.xml","form_type":"4"}},{"id":2438171,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-11T21:18:07.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023."}],"balance_after":37461,"source":{"system":"sec-edgar","filing":"0001179110-22-000397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000397/edgar.xml","form_type":"4"}},{"id":2438170,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-11T21:18:07.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":775,"price":38.525,"value":29856.875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 203 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 224 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021."}],"balance_after":16461,"source":{"system":"sec-edgar","filing":"0001179110-22-000397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911022000397/edgar.xml","form_type":"4"}},{"id":2653715,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-28T12:40:07.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":6006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."}],"balance_after":6006,"derivative":{"exercise_price":19.98,"expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":6006},"source":{"system":"sec-edgar","filing":"0001171520-21-000266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000117152021000266/ownership.xml","form_type":"4"}},{"id":2653714,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T12:40:07.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":3003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."}],"balance_after":3003,"source":{"system":"sec-edgar","filing":"0001171520-21-000266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808968/000117152021000266/ownership.xml","form_type":"4"}},{"id":2743359,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-04-21T20:09:37.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":197,"price":47.919,"value":9440.043,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.68 to $48.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":16809,"source":{"system":"sec-edgar","filing":"0001179110-21-004535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021004535/edgar.xml","form_type":"4"}},{"id":2743358,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-04-21T20:09:37.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":1444,"price":46.582,"value":67264.408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.24 to $47.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":17006,"source":{"system":"sec-edgar","filing":"0001179110-21-004535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021004535/edgar.xml","form_type":"4"}},{"id":2743357,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-04-21T20:09:37.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":859,"price":48.168,"value":41376.312,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from a April 16, 2020 grant of 10,000 RSUs."}],"balance_after":18450,"source":{"system":"sec-edgar","filing":"0001179110-21-004535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021004535/edgar.xml","form_type":"4"}},{"id":2903013,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T21:10:50.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":4300,"price":38.98,"value":167614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on October 25, 2019, and vests over four years, with 25% of the shares underlying the option vesting on October 28, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on January 28, 2021."}],"balance_after":86314,"derivative":{"exercise_price":38.98,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":4300},"source":{"system":"sec-edgar","filing":"0001179110-21-000733","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000733/edgar.xml","form_type":"4"}},{"id":2903012,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-20T21:10:50.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":4300,"price":69.088,"value":297078.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.98 to $69.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":19309,"source":{"system":"sec-edgar","filing":"0001179110-21-000733","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000733/edgar.xml","form_type":"4"}},{"id":2903011,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-20T21:10:50.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":4300,"price":38.98,"value":167614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."}],"balance_after":23609,"source":{"system":"sec-edgar","filing":"0001179110-21-000733","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000733/edgar.xml","form_type":"4"}},{"id":2909881,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-12T21:17:12.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":5500,"price":38.98,"value":214390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on October 25, 2019, and vests over four years, with 25% of the shares underlying the option vesting on October 28, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on January 28, 2021."}],"balance_after":90614,"derivative":{"exercise_price":38.98,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001179110-21-000539","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000539/edgar.xml","form_type":"4"}},{"id":2909880,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-12T21:17:12.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":1500,"price":70.324,"value":105486.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.00 to $70.61 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":19309,"source":{"system":"sec-edgar","filing":"0001179110-21-000539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000539/edgar.xml","form_type":"4"}},{"id":2909879,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-12T21:17:12.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":4000,"price":69.481,"value":277924.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.98 to $69.93 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":20809,"source":{"system":"sec-edgar","filing":"0001179110-21-000539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000539/edgar.xml","form_type":"4"}},{"id":2909878,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-12T21:17:12.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":5500,"price":38.98,"value":214390.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."}],"balance_after":24809,"source":{"system":"sec-edgar","filing":"0001179110-21-000539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000539/edgar.xml","form_type":"4"}},{"id":2912646,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-08T22:12:54.000Z","date":"2021-01-07","kind":"exercise","acquired":false,"shares":3886,"price":38.98,"value":151476.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 25, 2019, and vests over four years, with 25% of the shares underlying the option vesting on October 28, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on January 28, 2021."}],"balance_after":96114,"derivative":{"exercise_price":39.98,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001179110-21-000467","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000467/edgar.xml","form_type":"4"}},{"id":2912645,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-08T22:12:54.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022."}],"balance_after":52500,"derivative":{"exercise_price":66.49,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001179110-21-000467","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000467/edgar.xml","form_type":"4"}},{"id":2912644,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-08T22:12:54.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":3886,"price":68.98,"value":268056.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."}],"balance_after":19309,"source":{"system":"sec-edgar","filing":"0001179110-21-000467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000467/edgar.xml","form_type":"4"}},{"id":2912643,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-08T22:12:54.000Z","date":"2021-01-07","kind":"exercise","acquired":true,"shares":3886,"price":38.98,"value":151476.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 2, 2020."}],"balance_after":23195,"source":{"system":"sec-edgar","filing":"0001179110-21-000467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000467/edgar.xml","form_type":"4"}},{"id":2912642,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-01-08T22:12:54.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 155 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2020 and 154 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2020."}],"balance_after":19309,"source":{"system":"sec-edgar","filing":"0001179110-21-000467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911021000467/edgar.xml","form_type":"4"}},{"id":3174570,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2020-04-17T20:28:50.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":50000,"price":47.49,"value":2374500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 16, 2020, and vests over four years, with 25% of the shares underlying the option vesting on April 16, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 16, 2021."}],"balance_after":50000,"derivative":{"exercise_price":47.49,"expiration_date":"2030-04-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001070081-20-000080","document":"wf-form4_158715531137252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000080/wf-form4_158715531137252.xml","form_type":"4"}},{"id":3174569,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":25961,"kind":"person","name":"Klein Matthew B.","position":1,"cik":"0001808968","reported_name":"Klein Matthew B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-04-17T20:28:50.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted on April 16, 2020 that vest in four equal installments over four years, commencing on April 16, 2021."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001070081-20-000080","document":"wf-form4_158715531137252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008120000080/wf-form4_158715531137252.xml","form_type":"4"}}]}